電気生理学の世界市場予測:製品別(ラボデバイス(3Dマッピング、記録)、アブレーションカテーテル(冷凍アブレーション、RF)、診断カテーテル(従来型、高度型、超音波型))、疾患別(AF、AVNRT、WPW)、エンドユーザー別(病院、ASC)

◆英語タイトル:Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording), Ablation Catheters (Cryoablation, RF), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), Indication (AF, AVNRT, WPW), End User (Hospitals, ASCs) - Global Forecasts to 2025
◆商品コード:MD 3273
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年7月15日
◆ページ数:205
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

MarketsandMarkets社は電気生理学の世界市場が2020年68億ドルから2025年106億ドルまで、年平均9.1%成長すると見込んでいます。本調査レポートでは、電気生理学の世界市場を詳細に調査・分析し、イントロダクション、調査手法、プレミアムインサイト、市場概要、種類別(電気生理学実験装置、電気生理学アブレーションカテーテル、電気生理学診断カテーテル、アクセスデバイス、その他)分析、疾患別(心房細動、心房粗動、房室結節結節性頻脈(AVNRT)、ウルフ・パーキンソン・ホワイト症候群(WPW)、その他)分析、エンドユーザー別(病院&心臓センター、外来手術センター)分析、地域別分析、競争状況、企業評価・企業概要などを含めており、ご提供いたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・電気生理学の世界市場規模:種類別(電気生理学実験装置、電気生理学アブレーションカテーテル、電気生理学診断カテーテル、アクセスデバイス、その他)
・電気生理学の世界市場規模:疾患別(心房細動、心房粗動、房室結節結節性頻脈(AVNRT)、ウルフ・パーキンソン・ホワイト症候群(WPW)、その他)
・電気生理学の世界市場規模:エンドユーザー別(病院&心臓センター、外来手術センター)
・電気生理学の世界市場規模:地域別
・競争状況
・企業評価・企業概要
【レポートの概要】

“Technological advancements and increasing incidence of target diseases to support market growth”
The global electrophysiology market is projected to reach USD 10.6 billion by 2025 from USD 6.8 billion in 2020, growing at a CAGR of 9.1% from 2020 to 2025. Factors driving the growth of the market are technological advancements; new entrants in the market; growing investments, funds, and grants; and increasing incidence of target diseases and procedures. Emerging markets are also expected to offer high growth opportunities for players operating in this market. However, factors such as high cost of electrophysiology products and inadequate reimbursement, unfavorable healthcare reforms in the US, and cost-intensive requirement for clinical data for new product launches along with availability of alternative technologies are expected to restrain the growth of this market in the coming years. The reuse and reprocessing of devices and lack of skilled and experienced electrophysiologists are some of the challenges in this market. The growth of the market is also expected to slow temporarily during the forecast period due to the COVID-19 pandemic.

“3D Mapping Systems: The largest segment of EP laboratory devices market”
Based on type of product, the EP laboratory devices market is segmented into 3D mapping systems, EP recording systems, RF ablation systems, intra-cardiac echocardiography (ICE) ultrasound imaging systems, EP X-ray systems, and other electrophysiology laboratory devices (MRI systems and EP remote magnetic and robotic navigation systems). 3D mapping systems accounted for the largest share of the global EP laboratory devices market in 2019. Driven by its high growth potential, markets players are increasingly focusing on the launch of new technologically advanced devices. For instance, in August 2018, BioSig Technologies received the US Food and Drug Administration (FDA) clearance for the PURE EP System.

“Cryoablation EP Catheters: The largest segment of EP ablation catheters market”
The EP ablation catheters market is further segmented into cryoablation EP catheters, radiofrequency ablation catheters, laser ablation systems, and microwave ablation systems. Cryoablation EP catheters accounted for the largest share of the global EP ablation catheters market in 2019. The therapeutic advantages of cryoablation over other ablation modalities such as radiofrequency ablation are driving the growth of this market. In addition, various market players are taking initiatives to increase their market presence and strengthen product portfolio; they are also engaging in clinical studies to evaluate the safety of their products. Such initiatives are further supporting market growth. In May 2019, Koninklijke Philips N.V. (Netherlands) entered into a partnership with Medtronic (Ireland). Philips’ KODEX-EPD dielectric imaging and navigation system, dielectric imaging sensors, clinical software and services were expected to be leveraged to support cryoablation procedures performed using the Medtronic Arctic Front Advance cryoablation technology.

“Conventional EP Diagnostic Catheters: The largest segment of EP diagnostic catheters market”
On the basis of type, the EP diagnostic catheters market is segmented into conventional EP diagnostic catheters, advanced EP diagnostic catheters, and ultrasound EP diagnostic catheters. The conventional EP diagnostic catheters segment accounted for the largest share of the global EP diagnostic catheters market in 2019. This can be attributed to the development of technologically advanced fixed and steerable diagnostic catheters, rising prevalence of cardiac arrhythmias across the globe, and increasing demand for these lower-priced devices in emerging markets.

“Atrial Fibrillation: The dominating indication segment of electrophysiology market”
Based on indication, the electrophysiology market is segmented into atrial fibrillation, atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-White (WPW) syndrome, atrial flutter, and other indications.
Atrial fibrillation segment commanded the largest share of the electrophysiology market in 2019; this segment is also expected to witness the highest growth during the forecast period. The rapid growth in the aging population across the globe, increasing prevalence of atrial fibrillation, growing number of ablation procedures related to atrial fibrillation, and the development of advanced electrophysiology products for early diagnosis of atrial fibrillation are expected to drive the growth of this market segment in the coming years.

“Hospitals & Cardiac Centers: The largest sub-segment of electrophysiology segment”
Based on end user, the global electrophysiology market has been segmented into hospitals & cardiac centers and ambulatory surgery centers. The hospitals & cardiac centers segment accounted for the largest share in 2019 due to the increasing ablation procedures, presence of big cath labs and electrophysiology labs in hospitals, and rising prevalence of CVDs. Technological advancements, coupled with government funding, are also encouraging the installation of new tools and devices in hospitals.

“North America: The largest share contributing reginal segment of the global electrophysiology market in 2019”
The electrophysiology market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. North America accounted for a major share of the electrophysiology market in 2019. Factors such as the high burden of CVDs, an increasing number of clinical trials validating electrophysiology devices, the growing number of approvals for electrophysiology devices, and the presence of key players in this region are driving the growth of the electrophysiology market in the US. Moreover, the growing focus of government organizations on providing funding for research, the rising geriatric population, and the high incidence of cardiac diseases are the major factors driving the electrophysiology market in Canada.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21%
• By Designation: C-level–47%, Director-level–33%, and Others–20%
• By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%

The major players in the market include Johnson & Johnson (US), Boston Scientific (US), Abbott Laboratories (US), Medtronic (Ireland), Koninklijke Philips N.V. (Royal Philips) (Netherlands), GE Healthcare (US), MicroPort Scientific Corporation (China), Stereotaxis (US), Imricor Medical Systems (US), EP Solutions (Switzerland), Epmap-System (Germany), OSYPKA AG (Germany), CardioFocus (US), CathVision (Denmark), Merit Medical Systems (US), BIOTRONIK (Germany), Siemens Healthineers (Germany), Lepu Medical (China), TZ Medical (US), Schwarzer Cardiotek GmbH (Germany), APN Health (US), Acutus Medical (US), Baylis Medical (Canada), Japan Lifeline (Japan), and CathRx (Australia).

Research Coverage
This report studies the breast biopsy market based on product, indication, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the electrophysiology market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the electrophysiology market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the electrophysiology market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

【レポートの目次】

1 INTRODUCTION (Page No. – 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 34)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION METHODOLOGY
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. – 43)
FIGURE 7 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 8 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (2020-2025)

4 PREMIUM INSIGHTS (Page No. – 47)
4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW
FIGURE 11 TECHNOLOGICAL ADVANCEMENTS – KEY FACTORS DRIVING GROWTH OF GLOBAL ELECTROPHYSIOLOGY MARKET
4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION
FIGURE 12 ATRIAL FIBRILLATION SEGMENT DOMINATED THE ASIA PACIFIC ELECTROPHYSIOLOGY MARKET IN 2019
4.3 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND REGION
FIGURE 13 ELECTROPHYSIOLOGY LABORATORY DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2019
4.4 ELECTROPHYSIOLOGY MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 14 HOSPITALS & CARDIAC CENTERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
4.5 GEOGRAPHICAL SNAPSHOT OF THE ELECTROPHYSIOLOGY MARKET
FIGURE 15 CHINA MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2020-2025)

5 MARKET OVERVIEW (Page No. – 51)
5.1 INTRODUCTION
FIGURE 16 EVOLUTION OF ELECTROPHYSIOLOGY
5.2 MARKET DYNAMICS
FIGURE 17 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Technological advancements
5.2.1.1.1 Non-invasive cardiac mapping
5.2.1.1.2 Improved ablation
5.2.1.1.3 MRI guided ablation procedures
5.2.1.1.4 Ultrasound guidance in the EP Lab
5.2.1.2 New entrants in the market
TABLE 2 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET
5.2.1.3 Growing investments, funds, and grants
5.2.1.4 Increasing incidence of target diseases and procedures
5.2.2 RESTRAINTS
5.2.2.1 High cost of electrophysiology products and inadequate reimbursement
5.2.2.2 Unfavorable healthcare reforms in the US
5.2.2.3 Cost-intensive requirement for clinical data for new product launches along with availability of alternative technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.4 CHALLENGES
5.2.4.1 Reuse and reprocessing of devices
5.2.4.2 Lack of skilled and experienced electrophysiologists
5.3 VALUE CHAIN ANALYSIS
FIGURE 18 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.4 REGULATORY ANALYSIS
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.2 Canada
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 19 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.4.2 EUROPE
FIGURE 20 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.4.3.3 India
5.5 COVID-19 IMPACT ON THE ELECTROPHYSIOLOGY MARKET

6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT (Page No. – 71)
6.1 INTRODUCTION
TABLE 8 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES
TABLE 9 EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 EP LABORATORY DEVICES MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 11 EP LABORATORY DEVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 12 EP LABORATORY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.1 3D MAPPING SYSTEMS
6.2.1.1 Alternative technologies likely to hinder market growth
TABLE 13 3D MAPPING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS
6.2.2.1 Increasing public-private funding to support market growth
TABLE 14 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS
6.2.3.1 Increased demand due to rising number of RF ablation procedures
TABLE 15 RF ABLATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUNG IMAGING SYSTEMS
6.2.4.1 Advantages of ICE ultrasound imaging systems to support market growth
TABLE 16 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS
6.2.5.1 Magnetic navigation systems to hamper market growth
TABLE 17 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.2.6 OTHER ELECTROPHYSIOLOGY LABORATORY DEVICES
6.2.6.1 Favorable reimbursement likely to bolster growth of market
TABLE 18 OTHER ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS
TABLE 19 EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 20 EP ABLATION CATHETERS MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 21 EP ABLATION CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 22 EP ABLATION CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.1 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS
6.3.1.1 Significant therapeutic advantages to contribute to market growth
TABLE 23 CRYOABLATION EP CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS
6.3.2.1 Technological advancements to drive the market
TABLE 24 RF ABLATION CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.3 MICROWAVE ABLATION (MWA) SYSTEMS
6.3.3.1 Advantages over RF ablation catheters to support market growth
TABLE 25 MWA SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.4 LASER ABLATION SYSTEMS
6.3.4.1 Technologically advanced products to boost market growth
TABLE 26 LASER ABLATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
TABLE 27 EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 28 EP DIAGNOSTIC CATHETERS MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 29 EP DIAGNOSTIC CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 30 EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.1.1 Increasing demand in emerging markets to support market growth
TABLE 31 CONVENTIONAL EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.2.1 Advantages over conventional EP diagnostic catheters likely to drive market growth
TABLE 32 ADVANCED EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
6.4.3.1 Increased demand due to rising use of ICE ultrasound imaging systems
TABLE 33 ULTRASOUND EP DIAGNOSTIC CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.5 ACCESS DEVICES
6.5.1 LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS LIKELY TO SUPPORT MARKET GROWTH
TABLE 34 ACCESS DEVICES MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 35 ACCESS DEVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 36 ACCESS DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.6 OTHER PRODUCTS
TABLE 37 OTHER PRODUCTS MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 38 OTHER PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 39 OTHER PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)

7 ELECTROPHYSIOLOGY MARKET, BY INDICATION (Page No. – 94)
7.1 INTRODUCTION
TABLE 40 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
7.2 ATRIAL FIBRILLATION
7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET GROWTH
TABLE 41 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2018–2025 (USD MILLION)
7.3 ATRIAL FLUTTER
7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATMENT OF ATRIAL FLUTTER CONTRIBUTING TO MARKET GROWTH
TABLE 42 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION, 2018–2025 (USD MILLION)
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
7.4.1 INCREASING VALIDATION OF EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR AVNRT SUPPORTING SEGMENT GROWTH
TABLE 43 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY REGION, 2018–2025 (USD MILLION)
7.5 WOLFF-PARKINSON-WHITE SYNDROME (WPW)
7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO TREAT WPW LIKELY TO SUPPORT MARKET GROWTH
TABLE 44 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE SYNDROME, BY REGION, 2018–2025 (USD MILLION)
7.6 OTHER INDICATIONS
TABLE 45 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION, 2018–2025 (USD MILLION)

8 ELECTROPHYSIOLOGY MARKET, BY END USER (Page No. – 101)
8.1 INTRODUCTION
TABLE 46 ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
8.2 HOSPITALS & CARDIAC CENTERS
8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE THE END-USER MARKET
TABLE 47 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2018–2025 (USD MILLION)
8.3 AMBULATORY SURGERY CENTERS
8.3.1 INCREASING NUMBER OF CENTERS IN THE US TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES
TABLE 48 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2018–2025 (USD MILLION)

9 ELECTROPHYSIOLOGY MARKET, BY REGION (Page No. – 105)
9.1 INTRODUCTION
TABLE 49 ELECTROPHYSIOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT
TABLE 50 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 NORTH AMERICA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 56 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2.1 US
9.2.1.1 Technological advancements driving market growth
TABLE 57 CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES
TABLE 58 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 59 US: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 US: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 US: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing government funding for research to support market growth
TABLE 62 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY
TABLE 63 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 64 CANADA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 CANADA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 CANADA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 67 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 69 EUROPE: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 EUROPE: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 71 EUROPE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 73 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market growth
TABLE 74 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 75 GERMANY: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 GERMANY: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 GERMANY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.2 UK
9.3.2.1 Growing geriatric population to support market growth
TABLE 78 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 79 UK: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 UK: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 81 UK: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increasing incidence of heart failure to support market growth
TABLE 82 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 83 FRANCE: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 FRANCE: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 FRANCE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Rising incidence of CVDs to drive the adoption of electrophysiology devices
TABLE 86 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 87 ITALY: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 ITALY: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 ITALY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing number of cardiac ablation procedures to drive market
TABLE 90 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 91 SPAIN: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 SPAIN: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 SPAIN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.3.6 REST OF EUROPE (ROE)
TABLE 94 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016
TABLE 95 ROE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 96 ROE: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 ROE: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 ROE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT
TABLE 99 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 100 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 101 ASIA PACIFIC: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 102 ASIA PACIFIC: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 ASIA PACIFIC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 105 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Favorable reimbursement scenario to support market growth
TABLE 106 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 107 JAPAN: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 JAPAN: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 JAPAN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Growing geriatric population to drive the market
TABLE 110 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 111 CHINA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 CHINA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 CHINA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Increasing healthcare initiatives by government supporting growth of market
TABLE 114 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 115 INDIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 INDIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 INDIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Increasing target disease burden to support market growth
TABLE 118 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 119 AUSTRALIA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 AUSTRALIA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 AUSTRALIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives expected to positively impact market growth
TABLE 122 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 123 SOUTH KOREA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 SOUTH KOREA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 125 SOUTH KOREA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 126 ROAPAC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 127 ROAPAC: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 ROAPAC: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 ROAPAC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.5 LATIN AMERICA
TABLE 130 LATAM: ELECTROPHYSIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 131 LATAM: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 132 LATAM: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 LATAM: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 LATAM: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 LATAM: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 136 LATAM: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Key market owing to modernization of healthcare facilities
TABLE 137 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 138 BRAZIL: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 BRAZIL: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 BRAZIL: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
TABLE 141 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 142 MEXICO: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 MEXICO: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 MEXICO: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 145 ROLA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 146 ROLA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 ROLA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 ROLA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
TABLE 149 MEA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 150 MEA: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 MEA: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 MEA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 MEA: ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION)
TABLE 154 MEA: ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. – 159)
10.1 INTRODUCTION
FIGURE 23 KEY DEVELOPMENTS IN THE ELECTROPHYSIOLOGY MARKET, 2017–2019
10.2 MARKET SHARE ANALYSIS
FIGURE 24 ELECTROPHYSIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
10.3 COMPETITIVE SCENARIO
10.3.1 PRODUCT LAUNCHES & APPROVALS
TABLE 155 PRODUCT LAUNCHES & APPROVALS (2017–2019)
10.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
TABLE 156 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019)
10.3.3 ACQUISITIONS
TABLE 157 ACQUISITIONS (2017–2019)

11 COMPANY EVOLUTION MATRIX & COMPANY PROFILES (Page No. – 163)
11.1 COMPETITIVE EVALUATION MATRIX AND METHODOLOGY
11.1.1 COMPETITVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS
11.1.2 VISIONARY LEADERS
11.1.3 INNOVATORS
11.1.4 EMERGING COMPANIES
11.1.5 DYNAMIC DIFFERENTIATORS
FIGURE 25 ELECTROPHYSIOLOGY MARKET COMPETITIVE LEADERSHIP MAPPING, 2019
11.2 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, Competitive analysis)*
11.2.1 JOHNSON & JOHNSON
FIGURE 26 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019)
11.2.2 ABBOTT LABORATORIES
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
11.2.3 MEDTRONIC PLC
FIGURE 28 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
11.2.4 KONINKLIJKE PHILIPS N.V.
FIGURE 29 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019)
11.2.5 GE HEALTHCARE
FIGURE 30 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
11.2.6 BOSTON SCIENTIFIC CORPORATION
FIGURE 31 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2019)
11.2.7 JAPAN LIFELINE
FIGURE 32 JAPAN LIFELINE: COMPANY SNAPSHOT (2019)
11.2.8 STEREOTAXIS
FIGURE 33 STEREOTAXIS: COMPANY SNAPSHOT (2019)
11.2.9 MICROPORT SCIENTIFIC CORPORATION
FIGURE 34 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
11.2.10 BIOTRONIK
11.2.11 ACUTUS MEDICAL
11.2.12 BAYLIS MEDICAL
11.2.13 EP SOLUTIONS SA
11.2.14 APN HEALTH, LLC
11.2.15 OSYPKA
11.2.16 EPMAP-SYSTEM
11.2.17 OTHER COMPANIES
11.2.17.1 CathRx Ltd
11.2.17.2 Merit Medical Systems
11.2.17.3 Cook Medical
11.2.17.4 CathVision
11.2.17.5 TZ Medical
11.2.17.6 Teleflex
11.2.17.7 Lepu Medical
11.2.17.8 Cardiofocus
11.2.17.9 Schwarzer Cardiotek
11.2.17.10 Imricor Medical Systems

*Business Overview, Products Offered, Recent Developments, Competitive analysis View might not be captured in case of unlisted companies.

12 APPENDIX (Page No. – 203)
12.1 DISCUSSION GUIDE: ELECTROPHYSIOLOGY MARKET
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[電気生理学の世界市場予測:製品別(ラボデバイス(3Dマッピング、記録)、アブレーションカテーテル(冷凍アブレーション、RF)、診断カテーテル(従来型、高度型、超音波型))、疾患別(AF、AVNRT、WPW)、エンドユーザー別(病院、ASC)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆